1-18 of 18
Arnon Nagler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study

Ali Bazarbachi, Myriam Labopin, Nour Moukalled, Nicolaus Kröger, Christina Rautenberg, Johannes Schetelig, Jürgen Finke, Igor Wolfgang Blau, Didier Blaise, Matthias Stelljes, Matthias Eder, Uwe Platzbecker, Peter Dreger, Wolfgang Bethge, Johanna Tischer, David Burns, Henrik Sengeloev, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1778–1787.
https://doi.org/10.1158/1078-0432.CCR-23-3673
Published: 01 May 2024
View article titled, Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
Open the PDF for Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study in another window
Includes: Supplementary data
Journal Articles

Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Remenyi, Edouard Forcade, Nicolaus Kröger, Gerard Socié, Charles Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Jordi Esteve, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (21): 4441–4448.
https://doi.org/10.1158/1078-0432.CCR-23-0954
Published: 01 November 2023
View article titled, Improved Posttransplant Outcomes in Recent Years for AML Patients with <em>FLT3</em>-ITD and Wild-type <em>NPM1</em>: A Report from the EBMT Acute Leukemia Working Party
Open the PDF for Improved Posttransplant Outcomes in Recent Years for AML Patients with <em>FLT3</em>-ITD and Wild-type <em>NPM1</em>: A Report from the EBMT Acute Leukemia Working Party in another window
Journal Articles

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis

Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, Myriam Labopin, Martin Bornhäuser, Matthias Stelljes, Jürgen Finke, Arnold Ganser, Herman Einsele, Nicolaus Kröger, Arne Brecht, Wolfgang Bethge, Matthias Edinger, Aleksandr Kulagin, Jakob Passweg, Igor Wolfgang Blau, Ahmet Elmaagacli, Kerstin Schäfer-Eckart, Uwe Platzbecker, Thomas Schroeder, Donald Bunjes, Johanna Tischer, Sonja Martin, Alexandros Spyridonidis, Sebastian Giebel, Bipin Savani, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4258–4266.
https://doi.org/10.1158/1078-0432.CCR-22-0809
Published: 03 October 2022
View article titled, Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis
Open the PDF for Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis in another window
Includes: Supplementary data
Journal Articles

20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Ali Bazarbachi, Myriam Labopin, Mahmoud Aljurf, Riitta Niittyvuopio, Marie Balsat, Didier Blaise, Ibrahim Yakoub-Agha, Anna Grassi, Hans Christian Reinhardt, Stig Lenhoff, Pavel Jindra, Jakob Passweg, Iman Abou Dalle, Michael Stadler, Bruno Lioure, Patrice Ceballos, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Christoph Schmid, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 1004–1012.
https://doi.org/10.1158/1078-0432.CCR-21-2675
Published: 03 March 2022
View article titled, 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
Open the PDF for 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation in another window
Journal Articles

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients

Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra, Alessandra Romano, Anna Marina Liberati, Donato Mannina, Paolo de Fabritiis, Nicola Cascavilla, Marina Ruggeri, Roberto Mina, Francesca Patriarca, Giulia Benevolo, Angelo Belotti, Gianluca Gaidano, Arnon Nagler, Roman Hájek, Andrew Spencer, Pieter Sonneveld, Pellegrino Musto, Mario Boccadoro, Francesca Gay
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3695–3703.
https://doi.org/10.1158/1078-0432.CCR-21-0134
Published: 01 July 2021
View article titled, Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Open the PDF for Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients in another window
Includes: Supplementary data
Journal Articles

Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia

Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Emanuele Angelucci, Boris Afanasyev, Jan J. Cornelissen, Simona Sica, Ellen Meijer, Fabio Ciceri, Gwendolyn Van Gorkom, Nicolaus Kröger, Hans Martin, Pietro Pioltelli, Antonio Risitano, Jonathan Canaani, Bipin N. Savani, Jaime Sanz, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3): 843–851.
https://doi.org/10.1158/1078-0432.CCR-20-2809
Published: 01 February 2021
View article titled, Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia
Open the PDF for Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia in another window
Includes: Supplementary data
Journal Articles

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi, Christoph Schmid, Myriam Labopin, Dietrich Beelen, Igor Wolfgang Blau, Victoria Potter, Riitta Niittyvuopio, Gerard Socié, Didier Blaise, Jaime Sanz, Fabio Ciceri, Iman Abou Dalle, Alexandros Spyridonidis, Gesine Bug, Jordi Esteve, Bipin N. Savani, Arnon Nagler, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6475–6482.
https://doi.org/10.1158/1078-0432.CCR-20-3134
Published: 15 December 2020
View article titled, Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Open the PDF for Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years in another window
Includes: Supplementary data
Journal Articles

Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

Frédéric Baron, Myriam Labopin, Annalisa Ruggeri, Jan J. Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger Niederwieser, Marco R. De Groot, Harry C. Schouten, Noel Milpied, Didier Blaise, Bipin N. Savani, Eliane Gluckman, Mohamad Mohty, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (12): 2794–2803.
https://doi.org/10.1158/1078-0432.CCR-17-3622
Published: 14 June 2018
View article titled, Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen
Open the PDF for Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen in another window
Includes: Supplementary data
Journal Articles

Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers

Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, Hana Wald, Orly Eizenberg, Katia Beider, Arnon Nagler, Rottem Golan, Abi Vainstein, Arnon Aharon, Eithan Galun, Yoseph Caraco, Reuven Or, Amnon Peled
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (22): 6790–6801.
https://doi.org/10.1158/1078-0432.CCR-16-2919
Published: 14 November 2017
View article titled, Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34<sup>+</sup> Cells in Healthy Volunteers
Open the PDF for Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34<sup>+</sup> Cells in Healthy Volunteers in another window
Includes: Supplementary data
Journal Articles

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia

Roni Shouval, Annalisa Ruggeri, Myriam Labopin, Mohamad Mohty, Guillermo Sanz, Gerard Michel, Jürgen Kuball, Patrice Chevallier, Amal Al-Seraihy, Noel-Jean Milpied, Cristina Diaz de Heredia, William Arcese, Didier Blaise, Vanderson Rocha, Joshua Fein, Ron Unger, Frederic Baron, Peter Bader, Eliane Gluckman, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (21): 6478–6486.
https://doi.org/10.1158/1078-0432.CCR-17-0489
Published: 31 October 2017
View article titled, An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia
Open the PDF for An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia in another window
Includes: Supplementary data
Journal Articles

The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway

Katia Beider, Evgenia Rosenberg, Hanna Bitner, Avichai Shimoni, Merav Leiba, Maya Koren-Michowitz, Elena Ribakovsky, Shiri Klein, Devorah Olam, Lola Weiss, Hanna Wald, Michal Abraham, Eithan Galun, Amnon Peled, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (7): 1733–1747.
https://doi.org/10.1158/1078-0432.CCR-15-2618
Published: 02 April 2017
View article titled, The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway
Open the PDF for The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway in another window
Includes: Supplementary data
Journal Articles

The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma

Amnon Peled, Michal Abraham, Irit Avivi, Jacob M. Rowe, Katia Beider, Hanna Wald, Lena Tiomkin, Lena Ribakovsky, Yossi Riback, Yaron Ramati, Sigal Aviel, Eithan Galun, Howard Laurence Shaw, Orly Eizenberg, Izhar Hardan, Avichai Shimoni, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2): 469–479.
https://doi.org/10.1158/1078-0432.CCR-13-1302
Published: 16 January 2014
View article titled, The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34<sup>+</sup> Cells in Patients with Multiple Myeloma
Open the PDF for The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34<sup>+</sup> Cells in Patients with Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies

Michal J. Besser, Ronnie Shapira-Frommer, Orit Itzhaki, Avraham J. Treves, Douglas B. Zippel, Daphna Levy, Adva Kubi, Noa Shoshani, Dragoslav Zikich, Yaara Ohayon, Daniel Ohayon, Bruria Shalmon, Gal Markel, Ronit Yerushalmi, Sara Apter, Alon Ben-Nun, Eytan Ben-Ami, Avichai Shimoni, Arnon Nagler, Jacob Schachter
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4792–4800.
https://doi.org/10.1158/1078-0432.CCR-13-0380
Published: 02 September 2013
View article titled, Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Open the PDF for Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies in another window
Includes: Supplementary data
Journal Articles

Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140

Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, Evgenia Rosenberg, Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3495–3507.
https://doi.org/10.1158/1078-0432.CCR-12-3015
Published: 30 June 2013
View article titled, Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140
Open the PDF for Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 in another window
Includes: Supplementary data
Journal Articles

Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

Michal J. Besser, Ronnie Shapira-Frommer, Avraham J. Treves, Dov Zippel, Orit Itzhaki, Liat Hershkovitz, Daphna Levy, Adva Kubi, Einat Hovav, Natalia Chermoshniuk, Bruria Shalmon, Izhar Hardan, Raphael Catane, Gal Markel, Sara Apter, Alon Ben-Nun, Iryna Kuchuk, Avichai Shimoni, Arnon Nagler, Jacob Schachter
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (9): 2646–2655.
https://doi.org/10.1158/1078-0432.CCR-10-0041
Published: 28 April 2010
View article titled, Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
Open the PDF for Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

Raanan Berger, Rinat Rotem-Yehudar, Gideon Slama, Shimon Landes, Abraham Kneller, Merav Leiba, Maya Koren-Michowitz, Avichai Shimoni, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3044–3051.
https://doi.org/10.1158/1078-0432.CCR-07-4079
Published: 15 May 2008
View article titled, Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
Open the PDF for Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies in another window
Journal Articles

Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma in Vivo

David J. Gross, Israel Reibstein, Lola Weiss, Shimon Slavin, Hagit Dafni, Michal Neeman, Mark Pines, Arnon Nagler
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3788–3793.
Published: 23 September 2003
View article titled, Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma <em>in Vivo</em>
Open the PDF for Treatment with Halofuginone Results in Marked Growth Inhibition of a von Hippel-Lindau Pheochromocytoma <em>in Vivo</em> in another window
Journal Articles

Inhibition of Matrix Metalloproteinase-2 Expression and Bladder Carcinoma Metastasis by Halofuginone

Michael Elkin, Reuven Reich, Arnon Nagler, Elena Aingorn, Mark Pines, Nathan de-Groot, Avraham Hochberg, Israel Vlodavsky
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 1982–1988.
Published: 01 August 1999
View article titled, Inhibition of Matrix Metalloproteinase-2 Expression and Bladder Carcinoma Metastasis by Halofuginone
Open the PDF for Inhibition of Matrix Metalloproteinase-2 Expression and Bladder Carcinoma Metastasis by Halofuginone in another window